Total Payments
$14,573
2024 Payments
$8,229
Companies
43
Transactions
342
Medicare Patients
10,588
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$7,849 (53.9%)
Other$6,460 (44.3%)
Education$247.49 (1.7%)
Travel$16.70 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,849 | 316 | 53.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,460 | 3 | 44.3% |
| Education | $247.49 | 21 | 1.7% |
| Travel and Lodging | $16.70 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $7,223 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $962.31 | 39 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $756.04 | 37 | $0 (2024) |
| Relypsa, Inc. | $557.29 | 18 | $0 (2020) |
| Horizon Therapeutics plc | $502.93 | 22 | $0 (2023) |
| OPKO Pharmaceuticals, LLC | $441.24 | 33 | $0 (2024) |
| Vifor Pharma, Inc. | $301.90 | 13 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $289.97 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $286.49 | 14 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $256.73 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,229 | 67 | Mallinckrodt Hospital Products Inc. ($6,866) |
| 2023 | $1,097 | 44 | Mallinckrodt Hospital Products Inc. ($238.27) |
| 2022 | $533.03 | 24 | Horizon Therapeutics plc ($149.39) |
| 2021 | $1,132 | 60 | AstraZeneca Pharmaceuticals LP ($378.12) |
| 2020 | $1,076 | 49 | AstraZeneca Pharmaceuticals LP ($240.17) |
| 2019 | $1,086 | 41 | AstraZeneca Pharmaceuticals LP ($269.49) |
| 2018 | $833.36 | 38 | Relypsa, Inc. ($217.52) |
| 2017 | $586.71 | 19 | PFIZER INC. ($132.31) |
All Payment Transactions
342 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Renalytix AI, Inc. | KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT (Device) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $122.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $2.11 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Rare Disease | ||||||
| 12/06/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.47 | General |
| 12/04/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/21/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: NEPHROLOGY | ||||||
| 11/06/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $27.02 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 10/24/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,720.00 | General |
| Category: CRITICAL CARE | ||||||
| 10/17/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $118.73 | General |
| Category: CRITICAL CARE | ||||||
| 10/17/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: NEPHROLOGY | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $23.78 | General |
| 10/11/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: CRITICAL CARE | ||||||
| 10/03/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $6.70 | General |
| Category: CRITICAL CARE | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $125.10 | General |
| Category: Cardio-renal | ||||||
| 09/25/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiology | ||||||
| 09/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $83.15 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 44 | 3,640 | 17,359 | $1.6M | $498,812 |
| 2022 | 44 | 3,052 | 16,181 | $1.4M | $436,735 |
| 2021 | 24 | 1,955 | 6,629 | $1.2M | $393,418 |
| 2020 | 23 | 1,941 | 5,244 | $1.0M | $379,069 |
Total Patients
10,588
Total Services
45,413
Medicare Billing
$1.7M
Procedure Codes
135
All Medicare Procedures & Services
135 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 294 | 964 | $292,063 | $104,718 | 35.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 373 | 1,128 | $238,234 | $81,442 | 34.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 93 | 224 | $190,091 | $44,068 | 23.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 231 | 255 | $102,732 | $30,404 | 29.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 160 | 179 | $105,413 | $28,325 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 172 | 322 | $125,364 | $26,001 | 20.7% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 79 | $83,591 | $25,755 | 30.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 44 | 212 | $56,693 | $20,556 | 36.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 28 | 74 | $64,739 | $20,123 | 31.1% |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | Office | 2023 | 23 | 2,940 | $62,857 | $18,184 | 28.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 41 | 205 | $42,015 | $14,014 | 33.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 24 | 217 | $32,876 | $9,620 | 29.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 37 | 155 | $19,220 | $8,441 | 43.9% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 124 | 192 | $19,814 | $7,766 | 39.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 95 | 129 | $35,546 | $6,711 | 18.9% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 126 | $24,494 | $5,910 | 24.1% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 41 | 41 | $15,534 | $4,869 | 31.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 110 | 162 | $11,988 | $4,700 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $11,200 | $3,410 | 30.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 172 | 366 | $3,564 | $3,033 | 85.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 18 | 18 | $11,067 | $2,833 | 25.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 144 | 250 | $6,600 | $2,588 | 39.2% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 114 | 178 | $6,064 | $2,378 | 39.2% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 26 | 62 | $8,007 | $2,228 | 27.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 12 | 12 | $5,849 | $1,982 | 33.9% |
About Dr. Emad Sedki, M.D
Dr. Emad Sedki, M.D is a Internal Medicine healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1649446766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emad Sedki, M.D has received a total of $14,573 in payments from pharmaceutical and medical device companies, with $8,229 received in 2024. These payments were reported across 342 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($7,849).
As a Medicare-enrolled provider, Sedki has provided services to 10,588 Medicare beneficiaries, totaling 45,413 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 135 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Manhasset, NY
- Active Since 05/08/2008
- Last Updated 10/16/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1649446766
Products in Payments
- TERLIVAZ (Drug) $6,898
- Veltassa (Drug) $765.25
- LOKELMA (Drug) $757.54
- JYNARQUE (Drug) $715.94
- KRYSTEXXA (Biological) $549.79
- ACTHAR (Biological) $524.03
- RAYALDEE (Drug) $386.91
- PURIFIED CORTROPHIN GEL (Drug) $249.35
- FARXIGA (Drug) $204.77
- ULTOMIRIS (Biological) $171.33
- NORTHERA (Drug) $164.23
- ENTRESTO (Drug) $153.90
- Kerendia (Drug) $150.41
- Velphoro (Drug) $148.05
- Auryxia (Drug) $144.46
- INJECTAFER (Drug) $144.39
- ELIQUIS (Drug) $132.31
- Pogo Automatic Blood Glucose Monitoring System (Device) $125.00
- VOQUEZNA (Drug) $122.19
- CONTRAVE (Drug) $121.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Manhasset
Anna Imperato, M.d, M.D
Internal Medicine — Payments: $593,858
Internal Medicine $593,858
Dr. Harmit Kalia, D.o, D.O
Internal Medicine — Payments: $45,969
Internal Medicine $45,969
Bradley Sherman, Md, MD
Internal Medicine — Payments: $31,930
Internal Medicine $31,930
Dr. Samy Selim, Md, MD
Internal Medicine — Payments: $24,755
Internal Medicine $24,755
Suchet Kumar, M.d, M.D
Internal Medicine — Payments: $9,358
Internal Medicine $9,358
Mr. Paul Schwartz, M.d, M.D
Internal Medicine — Payments: $7,084
Internal Medicine $7,084